Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response
Condition(s):Philadelphia Chromosome Positive; Chronic Myelogenous Leukemia in Chronic PhaseLast Updated:April 8, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Philadelphia Chromosome Positive; Chronic Myelogenous Leukemia in Chronic PhaseLast Updated:April 8, 2016Completed
Condition(s):CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE; CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISISLast Updated:August 7, 2020Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 12, 2019Unknown status
Condition(s):Chronic Myelogenous LeukemiaLast Updated:February 29, 2024Not yet recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:October 5, 2023Recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:May 28, 2019Completed
Condition(s):Chronic Myelogenous LeukemiaLast Updated:September 30, 2016Terminated
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 21, 2017Unknown status
Condition(s):Philadelphia Chromosome-Positive Chronic Myeloid LeukemiaLast Updated:March 13, 2024Recruiting
Condition(s):Chronic Myelogenous Leukemia; Hematologic MalignanciesLast Updated:May 16, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.